| CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin S Di Franco, B Parrino, M Gaggianesi, VD Pantina, P Bianca, A Nicotra, ... Iscience 24 (6), 2021 | 39 | 2021 |
| Messing up the cancer stem cell chemoresistance mechanisms supported by tumor microenvironment M Gaggianesi, S Di Franco, VD Pantina, G Porcelli, C D'Accardo, ... Frontiers in Oncology 11, 702642, 2021 | 33 | 2021 |
| Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy A Turdo, A Glaviano, G Pepe, F Calapà, S Raimondo, ME Fiori, ... Cancers 13 (16), 3927, 2021 | 31 | 2021 |
| Recapitulating thyroid cancer histotypes through engineering embryonic stem cells V Veschi, A Turdo, C Modica, F Verona, S Di Franco, M Gaggianesi, ... Nature Communications 14 (1), 1351, 2023 | 13 | 2023 |
| Targeting epigenetic alterations in cancer stem cells P VD, V V Frontiers in Molecular Medicine 2, 1011882, 2022 | 12 | 2022 |
| Cancer cell targeting by CAR-T cells: A matter of stemness C D’Accardo, G Porcelli, LR Mangiapane, C Modica, VD Pantina, ... Frontiers in Molecular Medicine 2, 1055028, 2022 | 4 | 2022 |
| Dual inhibition of myc transcription and PI3K activity effectively targets colorectal cancer stem cells M Gaggianesi, LR Mangiapane, C Modica, VD Pantina, G Porcelli, ... Cancers 14 (3), 673, 2022 | 4 | 2022 |
| Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression VD Pantina, F Verona, A Turdo, V Veschi, C Modica, ML Iacono, ... STAR protocols 5 (3), 103263, 2024 | | 2024 |